Adamis Pharmaceuticals Corporation (ADMP): What’s the analyst recommendation for ADMP?

Maxim Group announced it was Upgrade coverage of Adamis Pharmaceuticals Corporation in a research note on May 13, 2020. The analysts assigned a Buy rating to the stock. Dawson James rated the stock as a Neutral in a research noted published on February 27, 2020. Raymond James rated the stock as a Mkt perform in a research note published on November 26, 2019.

Daniels Karen K., the VP of Operations of Adamis Pharmaceuticals Corporation, sold 4855.0 shares at the valuation of $0.56 during an exchange that occurred on May 19, which implies that Daniels Karen K. is holding 146,144 shares at the estimation of $2,719 dependent on the most recent closing price.

In another transaction, on May 18, Chief Financial Officer of Adamis Pharmaceuticals Corporation, Hopkins Robert O, sold 6532.0 shares at the price of $0.56. After this activity, Hopkins Robert O now keeps 302,199 shares of Adamis Pharmaceuticals Corporation, esteemed at $3,659 with the most recent shutting price.

ADMP Recent Trade

The share price of ADMP ascended by $0.06 during the exchanging session on 07/28/20 to exchange at $1.11. Adamis Pharmaceuticals Corporation stock has an exchanging volume of 14.32 million shares, which is high, contrasted with its 3-months average volume of 3.98M shares. Its market capitalization has now reached to $79.35M and analysts have a consensus target price of $1.25 in the 12-month period.

ADMP Past Trading Activity

The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, ADMP price has rose by 17.06%. In the course of past three months sees the stock go up around 143.66%, while it has gain 61.20% over the past six months and 57.77% since the start of the year.

ADMP Earning History

Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Jun 2020), the firm recorded a revenue of 4.66 billion, which was higher than the gauge of 5.27M made by certain experts. For that equivalent quarter, Adamis Pharmaceuticals Corporation posted -$0.15 earnings per share (EPS) which was underneath the consensus estimate of -$0.06 by -$0.09, which represents to a reduction by -150.00%.

ADMP Price Performance

Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on Adamis Pharmaceuticals Corporation has seen its stock exchanging -10.16% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +156.86% above its three-month low. A more extensive look sees ADMP exchanging -23.26% beneath its 52-week high and 309.26% above from its 52-week low price.

ADMP Instability & Beta Factor

The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 19.44%, while it has a month to month instability of 16.00%. The company has an ATR (Average True Range) of 0.12 and a beta factor of 2.27.

Leave a Comment